Skip to content

New Feature Updates

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page features that can be enabled. Read below to see how you can use these features to make sure all patients are ready to go prior to your appointments and key information is reinforced, reducing time costly omissions.

Customize Your Consents

If you wish to create your own consents and make them part of your intake forms, we now have an easier process to do so. 

When logged in, hover over your settings and select the ‘Patient Portal’ setting.

Once there, turn the ‘Custom Consent’ to ‘Yes’ and a label and text box will appear.  Here you can enter the text that you require patients to sign. 

If you have more than one consent that you require, select the + button to the right of the text box to generate a new label and box.  When you are done, hit the ‘Update’ button.  The consent(s) will now be live on your intake forms and will be time-stamped, signed, and stored with the medical record.

Customize Your Intake Confirmation Page

If you want to remind patients of what to bring to an appointment, direct them to state registries, or simply just list your location again, we now have an easy way to do so with our ‘Directory Profile’ setting.

Once logged in, hover over Settings and select ‘Directory Profile’. 

Scroll down to the text box labeled ‘Thank You Page Text’ and type or paste your customized message.  The box accepts html so you can customize its content and appearance even more. Once you are done, select ‘Update’ and your new ‘Confirmation/Thank You’ page will be displayed after a patient completes the intake form.

Stories you may be interested in

Norfolk research company plans clinical trials using medical marijuana

Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More

Cannabis reduces blood pressure in older adults, according to Ben-Gurion University researchers

Beer-Sheva, Israel…February 8, 2021 – A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults. The study, published in the European Journal of Internal Medicine, is the first of its kind to focus on the effect…
Read More

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More

Finally, Georgia can grow medical marijuana. Here’s what you need to know.

Four years ago, Governor Nathan Deal signed into law Haleigh’s Hope Act, which made low-THC cannabis oil legal to use by those with certain medical conditions. However, as it was still against the law to buy or grow marijuana in the state, it was virtually impossible to obtain the oil in Georgia. Patients were forced…
Read More

Data Migration During EMR Changes

One of the most challenging aspects when deciding to switch to a new EMR system is how to get existing data from the old system to the new system safely, securely and accurately.  Many times, the scope of this task is enough to force providers to remain with a subpar vendor even though there are…
Read More

Former Detroit Lions players announce partnership with Harvard to study marijuana

Former Detroit Lions football players Calvin Johnson and Robert Sims are expanding their emerging cannabis enterprise into the field of medicine. The pair announced an agreement Thursday with the International Phytomedicines and Medical Cannabis Institute at Harvard University, which is researching the benefits of medical marijuana and looking at the best ways to deliver cannabis-based…
Read More

Leave a Comment

You must be logged in to post a comment.